Out of Nowhere: Do You Need to Prepare for Highly Improbable Situations? - Being open to unforseen events may avert risk or create opportunities. - BioPharm International

ADVERTISEMENT

Out of Nowhere: Do You Need to Prepare for Highly Improbable Situations?
Being open to unforseen events may avert risk or create opportunities.


BioPharm International
Volume 23, Issue 6

LOCALIZED EVENTS

Taleb does not limit his discussion of black swans to global events. Rather, improbable events can happen at a more localized level, and the consequences can be more contained, even though severe for those affected.

For instance, consider the implications of warning letters, which have hit a number of contract manufacturers. Warning letters generally have been considered improbable events, especially at CMOs and CROs, which are expected to maintain high levels of compliance and are audited frequently by clients. When they do occur, however, clients risk having the flow of product to patients interrupted and their revenues and profits drastically cut. The CMO or CRO faces the high cost of remediation, the distraction of dealing with the regulators and nervous clients, and the prospect of convincing prospective new clients that it is a reliable company.

OPENING UP TO POSSIBILITIES

Black swans present a classic risk management problem for those who should be addressing them: They are low probability events, so they don't seem to deserve a lot of attention, but their impact can be so catastrophic that it would be foolish not address them. Even if companies run risk-management scenarios or Monte Carlo–type simulations, they may conclude that the probability of such events is so small that they are not worth the effort to address them. More likely, they will fail to anticipate the chain of developments that might lead to a catastrophic outcome, the "one-in-a-million" confluence of events that no one saw coming.

At same time, Taleb notes, black swans events can create unforeseen opportunities, like the side effects of sildenafil. The challenge for decision-makers in the case of improbable positive events is to be open enough to seize an unexpected opportunity when it presents itself, and not ignore it just because it doesn't fit the five-year business plan.

In the end, Taleb says that we must "shed the idea of full predictability," and "be prepared for all relevant eventualities." Improbable does not mean impossible.

Jim Miller is president of PharmSource Information Services, Inc. , Springfield, VA, 703.383.4903,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here